These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27094781)

  • 21. Effect of translocator protein (18 kDa)-ligand binding on neurotransmitter-induced salivary secretion in rat submandibular glands.
    Ostuni MA; Tumilasci OR; Péranzi G; Cardoso EM; Contreras LN; Arregger AL; Papadopoulos V; Lacapere JJ
    Biol Cell; 2008 Jul; 100(7):427-39. PubMed ID: 18269350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer.
    Denora N; Laquintana V; Lopalco A; Iacobazzi RM; Lopedota A; Cutrignelli A; Iacobellis G; Annese C; Cascione M; Leporatti S; Franco M
    J Control Release; 2013 Dec; 172(3):1111-25. PubMed ID: 24096015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.
    Simorini F; Marini AM; Taliani S; La Motta C; Salerno S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2012; 12(4):333-51. PubMed ID: 22204487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic and Anti-depressive Like Effects of Translocator Protein (18 kDa) Ligand YL-IPA08 in a Rat Model of Postpartum Depression.
    Ren P; Ma L; Wang JY; Guo H; Sun L; Gao ML; Liu YZ; Ma YQ; Li YF; Guo WZ
    Neurochem Res; 2020 Aug; 45(8):1746-1757. PubMed ID: 32383026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173.
    Costa B; Da Pozzo E; Cavallini C; Taliani S; Da Settimo F; Martini C
    ACS Chem Neurosci; 2016 Aug; 7(8):1041-6. PubMed ID: 27385308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clock-Controlled Mitochondrial Dynamics Correlates with Cyclic Pregnenolone Synthesis.
    Witzig M; Grimm A; Schmitt K; Lejri I; Frank S; Brown SA; Eckert A
    Cells; 2020 Oct; 9(10):. PubMed ID: 33086741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C; Baghai TC; Schüle C; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of Codium fragile against UVB-induced pro-inflammatory and oxidative damages in HaCaT cells and BALB/c mice.
    Lee C; Park GH; Ahn EM; Kim BA; Park CI; Jang JH
    Fitoterapia; 2013 Apr; 86():54-63. PubMed ID: 23396144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation- related Degenerative Diseases.
    Tremolanti C; Germelli L; Barresi E; Da Pozzo E; Simorini F; Castellano S; Taliani S; Da Settimo F; Martini C; Costa B
    Curr Med Chem; 2022 Aug; 29(28):4831-4861. PubMed ID: 35430971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).
    Reynolds A; Hanani R; Hibbs D; Damont A; Da Pozzo E; Selleri S; Dollé F; Martini C; Kassiou M
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5799-802. PubMed ID: 20727749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.
    Raso GM; Esposito E; Vitiello S; Iacono A; Santoro A; D'Agostino G; Sasso O; Russo R; Piazza PV; Calignano A; Meli R
    J Neuroendocrinol; 2011 Jul; 23(7):591-600. PubMed ID: 21554431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoprotective effects of paeoniflorin are associated with translocator protein 18 kDa.
    Qiu ZK; Liu X; Tang D; Zhang Z; Fan QH; Pan YY; Chen YY; Huang MY; Zhu T; Wang YL; Cheng XF; Chen JS
    Biomed Pharmacother; 2018 Nov; 107():19-23. PubMed ID: 30075369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
    Rupprecht R; Pradhan AK; Kufner M; Brunner LM; Nothdurfter C; Wein S; Schwarzbach J; Puig X; Rupprecht C; Rammes G
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1477-1487. PubMed ID: 36574032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO).
    Banister SD; Beinat C; Wilkinson SM; Shen B; Bartoli C; Selleri S; Da Pozzo E; Martini C; Chin FT; Kassiou M
    Eur J Med Chem; 2015 Mar; 93():392-400. PubMed ID: 25725375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
    Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?
    Rupprecht R; Wetzel CH; Dorostkar M; Herms J; Albert NL; Schwarzbach J; Schumacher M; Neumann ID
    Mol Psychiatry; 2022 Jul; 27(7):2918-2926. PubMed ID: 35444254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of N,N-Dialkyl-2-arylindol-3-ylglyoxylamides.
    Costa B; Taliani S; Da Pozzo E; Barresi E; Robello M; Cavallini C; Cosconati S; Da Settimo F; Novellino E; Martini C
    ChemMedChem; 2017 Aug; 12(16):1275-1278. PubMed ID: 28467680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.
    Costa B; Da Pozzo E; Giacomelli C; Barresi E; Taliani S; Da Settimo F; Martini C
    Sci Rep; 2016 Jan; 6():18164. PubMed ID: 26750656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.